Skip to main content
. Author manuscript; available in PMC: 2022 Feb 26.
Published in final edited form as: Vaccine. 2021 Sep 14;39(42):6302–6307. doi: 10.1016/j.vaccine.2021.08.099

Fig. 2.

Fig. 2.

Difference-in-differences accounting for pre-intervention differences. Difference-in-difference in cumulative incidence of each outcome during each influenza season comparing the difference in mean outcome in each district in an intervention year compared to the three pre-intervention years (2011–2013). Difference-in-difference parameters remove any time-invariant differences between groups (measured or unmeasured). Parameters were estimated using a generalized linear model without covariate adjustment due to data sparsity. Standard errors accounted for clustering at the household level. Estimates in children 5–12 years measure total effects and estimates in other age groups measure indirect effects. Analyses were restricted to influenza season defined based the percentage of medical visits for influenza-like illness in California as reported by the California Department of Public Health. Influenza season started when there were at least 2 consecutive weeks in which the percentage of medical visits for influenza-like illness exceeded 2%, and the season ended when there were at least two consecutive weeks in which the percentage was less than or equal to 2%.